Anastrozole EP Impurity E


This product has a 5% Discount Online | Login to view price instantly
Product Details

CAT No.# CS-CB-00029
Category Impurities
CAS 120511-88-8
Molecular Weight 242.32
Molecular Formula C15H18N2O
Synonyms: 2,2'-(5-(hydroxymethyl)-1,3-phenylene)bis(2-methylpropanenitrile); 1,3-Benzenediacetonitrile, 5-(hydroxymethyl)-a1,a1,a3,a3-tetramethyl; 2-[3-(Cyanodimethylmethyl)-5-hydroxymethylphenyl]-2-methylpropionitrile)
Application Notes: 2-[3-(Cyanodimethylmethyl)-5-hydroxymethylphenyl]-2-methylpropionitrile (Anastrozole EP Impurity E ) is an impurity of Anastrozole (A637425), an aromatase inhibitor which functions as an antineoplastic (1,2). Anastrozole is used in post-menopausal women with advanced breast cancer.
References: 1. Plourde, P. et al.: Breast Cancer Res Treat. 1994;30(1):103-11 2. Buzdar, A. et al.: Cancer. 1997 Feb 15;79(4):730-9.
Shipping: Free Shipping for worldwide on order above 2000 USD
Anastrozole EP Impurity E Worldwide Suppliers of Anastrozole EP Impurity E Impurities Clearsynth CS-CB-00029

Product rating: 9 Anastrozole EP Impurity E based on 20 ratings

  1. Impurities
  2. Anastrozole EP Impurity E

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Ortho toluene sulfonic acid
15. Crisaborole m-Isomer
16. Riluzole (1604337)
17. Pheniramine impurity B
18. Palbociclib N-Glucuronide
19. Carpropamid
20. Olmesartan N1-Trityl Impurity

This page contains information about Anastrozole EP Impurity E Cas 120511-88-8 and its Impurities.

Anastrozole EP Impurity E Anastrozole EP Impurity E Worldwide Suppliers of Anastrozole EP Impurity E Impurities Clearsynth 120511-88-8

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."